Skip to main content
Poltreg S.A. logo

Poltreg S.A. — Investor Relations & Filings

Ticker · PTG ISIN · PLPLTRG00038 LEI · 259400XSAJTERJ42VZ86 WAR Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2024-01-12 Regulatory Filings
Country PL Poland
Listing WAR PTG

About Poltreg S.A.

https://poltreg.com/

Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.

Recent filings

Filing Released Lang Actions
Warunkowe przyznanie patentu przez Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych w projekcie leczenia cukrzycy typu 1 - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement by the Management Board (Zarząd) of PolTREG S.A. regarding receiving a conditional decision to grant a patent from the United States Patent and Trademark Office (USPTO) for a diabetes vaccine invention. This concerns intellectual property rights and legal/regulatory matters related to the company's development pipeline. It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It specifically details a legal/regulatory outcome concerning intellectual property, which aligns best with the 'Legal Proceedings Report' (LTR) category, as patent grants/disputes fall under significant legal/regulatory matters affecting the company's assets and operations. Given the short length and the nature of the announcement (reporting a specific event), it is not a general 'Regulatory Filing' (RNS) unless LTR is deemed inappropriate, but LTR is a better fit for patent news.
2024-01-12 Polish
Zakończenie budowy zakładu do produkcji terapii komórkowych - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a current report (raport bieżący) from a Polish company (PolTREG S.A.) detailing the completion of construction phases (I and II) for an investment related to a cell therapy production plant. It discusses achieving GMP compliance for the first unit, ongoing work on the second unit, and the process of obtaining necessary certifications from regulatory bodies (GIF, KCBTiK) to produce ATMP (Advanced Therapy Medicinal Products). It also mentions that completing this investment was one of the emission goals from a 2021 public offering. This content relates to significant operational progress, regulatory milestones, and capital expenditure realization, which strongly aligns with updates on financing activities, capital structure changes, or major operational developments that impact the company's structure and future capacity. Given the focus on the completion of a major, funded project (involving PARP funding) and the subsequent steps toward commercial/clinical production capability, the most fitting category is Capital/Financing Update (CAP), as this investment was tied to a prior public offering (fundraising goal) and significantly alters the company's capital deployment and production capacity. It is not a standard financial report (IR/10-K), an earnings release (ER), or a management discussion (MDA), but rather a specific update on a major strategic asset development.
2023-12-22 Polish
Kwartalny raport finansowy Q3 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Kwartalny raport finansowy' (Quarterly Financial Report) for the third quarter of 2023. It contains comprehensive financial statements, including the statement of comprehensive income, statement of financial position, statement of changes in equity, and statement of cash flows, along with detailed notes and management commentary. As it covers a period shorter than a full fiscal year and contains substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2023
2023-11-23 Polish
Odwołanie osoby zarządzającej - Content (PL)
Board/Management Information Classification · 98% confidence The document text is very short (240 characters) and announces a change in the company's management structure. Specifically, it states that the Supervisory Board resolved to dismiss Ms. Kamilla Bok from the Management Board as of September 27, 2023. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-09-27 Polish
Raport biegłego rewidenta z przeglądu sprawozdania finansowego
Audit Report / Information Classification · 99% confidence The document is titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU" (Independent Auditor's Review Report) concerning the "śródrocznego sprawozdania finansowego" (interim financial statement) for the period ending 30.06.2023. This clearly indicates it is a report related to an audit or review of financial statements for a period shorter than a year. The definition for Audit Report / Information (AR) covers "Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)". Since this is a review report on an interim financial statement, AR is the most appropriate classification, distinguishing it from the full Annual Report (10-K) or a general Interim Report (IR) which typically contains the statements themselves, not the auditor's opinion/review. H1 2023
2023-09-07 Polish
Sprawozdanie Zarządu z działalności za okres 6 miesięcy zakończony dnia 30 czerwca 2023 roku
Management Reports Classification · 99% confidence The document is titled "Sprawozdanie Zarządu z działalności W okresie od 01.01.2023 do 30.06.2023" (Management Report on activities for the period from 01.01.2023 to 30.06.2023). It contains a detailed Table of Contents covering financial data, business activities, risk factors, management structure, and includes selected financial data comparing the first half of 2023 with previous periods. This structure and content strongly indicate a comprehensive report covering a period shorter than a full year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K) because the period covered is only six months.
2023-09-07 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.